Relmada Therapeutics Ownership 2024 | Who Owns Relmada Therapeutics Now?
Institutional Ownership
10.52%
Insider Ownership
8.04%
Retail Ownership
81.44%
Institutional Holders
27.00
Relmada Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 4.17% | 0.00% | 1,256,705 | - | - | 3,770,115 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 4.10% | 0.11% | 1,234,773 | -5,261 | -0.42% | 3,704,319 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 3.98% | 0.27% | 1,200,000 | - | - | 3,600,000 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 3.96% | 0.01% | 1,193,333 | 12,147 | 1.03% | 3,577,000 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 3.36% | 0.00% | 1,012,661 | 382,410 | 60.68% | 3,037,983 | Jun 30, 2024 |
| PARSONS CAPITAL MANAGEMENT INC/RI | 3.24% | 0.20% | 975,945 | 2,425 | 0.25% | 2,927,835 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 2.43% | 0.25% | 732,400 | - | - | 2,197,200 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.99% | 0.41% | 600,000 | -159,000 | -20.95% | 1,800,000 | Jun 30, 2024 |
| BLACKROCK INC. | 1.90% | - | 573,314 | -4,874 | -0.84% | 1,719,942 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.17% | 0.00% | 352,616 | 176,638 | 100.38% | 1,057,848 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.86% | 0.00% | 260,498 | 4,411 | 1.72% | 781,692 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.79% | 0.07% | 237,874 | 237,492 | 62170.68% | 713,622 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.75% | 0.00% | 224,846 | - | - | 674,538 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.69% | 0.00% | 207,969 | -2,607 | -1.24% | 623,907 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.67% | 0.00% | 203,261 | -23,778 | -10.47% | 609,783 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.60% | 0.01% | 181,077 | -14,700 | -7.51% | 543,231 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.55% | 0.03% | 165,474 | - | - | 496,422 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.52% | 0.00% | 156,619 | -51,251 | -24.66% | 469,857 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.49% | 0.00% | 148,927 | -35,411 | -19.21% | 446,781,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.48% | 0.00% | 145,999 | - | - | 438,000 | Jun 30, 2024 |
Relmada Therapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 4.17% of the company's total share outstanding, currently valued at $3.77M. The top 10 institutional shareholders own together 30.31% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OPALEYE MANAGEMENT INC. | 1.99% | 0.41% | 600,000 | -159,000 | -20.95% | 1,800,000 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 3.98% | 0.27% | 1,200,000 | - | - | 3,600,000 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 2.43% | 0.25% | 732,400 | - | - | 2,197,200 | Jun 30, 2024 |
| GUILD INVESTMENT MANAGEMENT, INC. | 0.24% | 0.25% | 73,596 | -117,404 | -61.47% | 220,788 | Jun 30, 2024 |
| PARSONS CAPITAL MANAGEMENT INC/RI | 3.24% | 0.20% | 975,945 | 2,425 | 0.25% | 2,927,835 | Jun 30, 2024 |
| APRICUS WEALTH, LLC | 0.26% | 0.17% | 78,862 | - | - | 236,586 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 4.10% | 0.11% | 1,234,773 | -5,261 | -0.42% | 3,704,319 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.79% | 0.07% | 237,874 | 237,492 | 62170.68% | 713,622 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.33% | 0.07% | 99,379 | - | - | 298,137 | Jun 30, 2024 |
| ADVISORSHARES INVESTMENTS LLC | 0.30% | 0.05% | 90,028 | 19,975 | 28.51% | 276,386 | Jun 30, 2024 |
| SPOTLIGHT ASSET GROUP, INC. | 0.07% | 0.04% | 20,000 | - | - | 60,000 | Jun 30, 2024 |
| PEGASUS ASSET MANAGEMENT, INC. | 0.09% | 0.03% | 26,958 | - | - | 80,874 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.17% | 0.03% | 50,601 | 50,000 | 8319.47% | 151,803 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.55% | 0.03% | 165,474 | - | - | 496,422 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.36% | 0.02% | 108,115 | 4,794 | 4.64% | 324,000 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.13% | 0.02% | 40,369 | - | - | 121,107 | Jun 30, 2024 |
| MGO ONE SEVEN LLC | 0.33% | 0.01% | 100,000 | - | - | 300,000 | Jun 30, 2024 |
| SARGENT INVESTMENT GROUP, LLC | 0.07% | 0.01% | 21,460 | -358 | -1.64% | 64,380 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.60% | 0.01% | 181,077 | -14,700 | -7.51% | 543,231 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 3.96% | 0.01% | 1,193,333 | 12,147 | 1.03% | 3,577,000 | Jun 30, 2024 |
The largest Relmada Therapeutics shareholder by % of total assets is OPALEYE MANAGEMENT INC.. The company owns 600.00K shares of Relmada Therapeutics (RLMD), representing 0.41% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC | 3.36% | 0.00% | 1,012,661 | 382,410 | 60.68% | 3,037,983 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.79% | 0.07% | 237,874 | 237,492 | 62170.68% | 713,622 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.17% | 0.00% | 352,616 | 176,638 | 100.38% | 1,057,848 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.29% | 0.00% | 88,775 | 53,767 | 153.58% | 266,325 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.17% | 0.03% | 50,601 | 50,000 | 8319.47% | 151,803 | Jun 30, 2024 |
| ADVISORSHARES INVESTMENTS LLC | 0.30% | 0.05% | 90,028 | 19,975 | 28.51% | 276,386 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.07% | - | 19,900 | 19,900 | 100.00% | 62,685 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 3.96% | 0.01% | 1,193,333 | 12,147 | 1.03% | 3,577,000 | Jun 30, 2024 |
| BEACON POINTE ADVISORS, LLC | 0.03% | 0.00% | 10,090 | 10,090 | 100.00% | 30,270 | Jun 30, 2024 |
| FMR LLC | 0.30% | - | 90,359 | 6,512 | 7.77% | 271,077 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.36% | 0.02% | 108,115 | 4,794 | 4.64% | 324,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.86% | 0.00% | 260,498 | 4,411 | 1.72% | 781,692 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.10% | 0.00% | 31,618 | 4,027 | 14.60% | 94,854 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.05% | - | 15,428 | 2,933 | 23.47% | 46,285 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 2,865 | 2,865 | 100.00% | 9,000 | Jun 30, 2024 |
| PARSONS CAPITAL MANAGEMENT INC/RI | 3.24% | 0.20% | 975,945 | 2,425 | 0.25% | 2,927,835 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 53 | 53 | 100.00% | 159 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | - | 35 | 35 | 100.00% | 104 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | - | 5 | 5 | 100.00% | 15 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 27 | - | - | 81 | Jun 30, 2024 |
As of Jun 30 2024, Relmada Therapeutics's largest institutional buyer is FRANKLIN RESOURCES INC. The company purchased 382.41K stocks of RLMD, valued at $3.04M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 0.21% | 0.00% | 64,357 | -277,093 | -81.15% | 193,071 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.99% | 0.41% | 600,000 | -159,000 | -20.95% | 1,800,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -118,243 | -100.00% | - | Jun 30, 2024 |
| GUILD INVESTMENT MANAGEMENT, INC. | 0.24% | 0.25% | 73,596 | -117,404 | -61.47% | 220,788 | Jun 30, 2024 |
| MORGAN STANLEY | 0.15% | - | 46,176 | -74,338 | -61.68% | 138,528 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 56 | -72,923 | -99.92% | 168 | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -72,318 | -100.00% | - | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | 0.03% | 0.01% | 10,000 | -63,500 | -86.39% | 30,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.52% | 0.00% | 156,619 | -51,251 | -24.66% | 469,857 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -51,161 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -49,882 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.26% | 0.00% | 78,893 | -47,023 | -37.34% | 236,679 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -45,249 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.12% | 0.00% | 35,425 | -43,588 | -55.17% | 106,275 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.49% | 0.00% | 148,927 | -35,411 | -19.21% | 446,781,000 | Jun 30, 2024 |
| MEYER HANDELMAN CO | - | - | - | -32,545 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -26,426 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -24,016 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.67% | 0.00% | 203,261 | -23,778 | -10.47% | 609,783 | Jun 30, 2024 |
| PDT PARTNERS, LLC | - | - | - | -16,227 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Relmada Therapeutics's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -0.28M shares of RLMD, valued at $193.07K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF MONTREAL /CAN/ | 0.07% | - | 19,900 | 19,900 | 100.00% | 62,685 | Jun 30, 2024 |
| BEACON POINTE ADVISORS, LLC | 0.03% | 0.00% | 10,090 | 10,090 | 100.00% | 30,270 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | - | 35 | 35 | 100.00% | 104 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | - | 5 | 5 | 100.00% | 15 | Jun 30, 2024 |
Relmada Therapeutics's largest new institutional shareholder by number of shares is BANK OF MONTREAL /CAN/, purchased 19.90K shares, valued at $62.69K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | - | - | - | -118,243 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -72,318 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -51,161 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -49,882 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -45,249 | -100.00% | - | Jun 30, 2024 |
| MEYER HANDELMAN CO | - | - | - | -32,545 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -26,426 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -24,016 | -100.00% | - | Jun 30, 2024 |
| PDT PARTNERS, LLC | - | - | - | -16,227 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -15,100 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -14,918 | -100.00% | - | Jun 30, 2024 |
| STRATOS WEALTH PARTNERS, LTD. | - | - | - | -14,100 | -100.00% | - | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -13,687 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -12,322 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -11,511 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -11,320 | -100.00% | - | Jun 30, 2024 |
| ACIMA PRIVATE WEALTH, LLC | - | - | - | -1,844 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -856 | -100.00% | - | Jun 30, 2024 |
| BLACKSTON FINANCIAL ADVISORY GROUP, LLC | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
Relmada Therapeutics's largest sold out institutional shareholder by shares sold is GOLDMAN SACHS GROUP INC, sold -0.12M shares, valued at -, as of undefined.
Relmada Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Health Sciences Trust II | 0.10% | 254,895 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.08% | 187,477 | 25,700 | 15.89% | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 20,489 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.04% | 96,010 | -3,829 | -3.84% | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.03% | 110,669 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.03% | 698 | - | - | Dec 31, 2023 |
| AdvisorShares Trust | 0.02% | 70,053 | -4,613 | -6.18% | Mar 28, 2024 |
| Vericimetry Funds | 0.01% | 1,280 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 52,182 | - | - | Aug 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 43,965 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,126 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.01% | 50,948 | -40,318 | -44.18% | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 6,118 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 940 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 6,397 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,205,541 | -406,414 | -25.21% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 51,585 | -597 | -1.14% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 29,525 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 62,799 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 233,477 | 10,619 | 4.76% | Feb 29, 2024 |
| Nushares ETF Trust | 0.00% | 6,372 | - | - | Jan 31, 2024 |
| BlackRock ETF Trust | 0.00% | 642 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,926 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 57,314 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 20,223 | -1,311 | -6.09% | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 21,416 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 6,336 | - | - | Mar 31, 2024 |
| Weiss Strategic Interval Fund | 0.00% | 1,163 | 1,163 | - | Sep 30, 2022 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 10,752 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 12,505 | - | - | Jan 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 5,208 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 119 | - | - | Apr 30, 2021 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 917 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 488 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 38,859 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 49,163 | - | - | Jan 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 587 | - | - | Mar 28, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 61,730 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 6,800 | - | - | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 7,955 | - | - | Jan 31, 2024 |
| GPS Funds I | 0.00% | 477 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 9,089 | 8,580 | 1685.66% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 252 | - | - | Dec 31, 2023 |
| FIDELITY SALEM STREET TRUST | 0.00% | 239,396 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 55,476 | - | - | Jan 31, 2024 |
| Chartwell Funds | 0.00% | 1,101 | - | - | Jun 30, 2022 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,110 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 95,691 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 3,882 | - | - | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 16,214 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 4,800 | 100 | 2.13% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 10,081 | - | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 14,428 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 900 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 125 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,102 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 347 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 2,558 | - | - | Feb 29, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 400 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 137 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 58,873 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 17,078 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 2,326 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 2,076 | - | - | Mar 28, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 17 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 3,240 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,812 | - | - | Jan 31, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 27,285 | - | - | Mar 31, 2024 |
| Series Portfolios Trust | 0.00% | 72 | - | - | Jan 31, 2024 |
| PGIM ETF TRUST | 0.00% | 721 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,086 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 9,068 | - | - | Mar 31, 2024 |
| VIRTUS ALTERNATIVE SOLUTIONS TRUST | 0.00% | 180 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 22,800 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,138 | - | - | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 3,760 | - | - | Jan 31, 2024 |
| AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS) | 0.00% | 120,541 | - | - | Jan 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 420 | - | - | Dec 31, 2023 |
| ALLSPRING MASTER TRUST | 0.00% | 387 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 13,430 | - | - | Dec 31, 2023 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 1,334 | - | - | Dec 31, 2023 |
| SPDR INDEX SHARES FUNDS | 0.00% | 752 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 4,206 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 55,233 | -1,385 | -2.45% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 70 | - | - | Jan 31, 2024 |
| iShares U.S. ETF Trust | 0.00% | 352 | - | - | Jan 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 71,649 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,975 | - | - | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 171 | - | - | Feb 29, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 5,500 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 5,075 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 123 | -29 | -19.08% | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 3,050 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,359 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 3,767 | - | - | Mar 28, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 52 | - | - | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,966 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 7,805 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 519 | 71 | 15.85% | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 2,556 | - | - | Feb 29, 2024 |
Relmada Therapeutics's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust II", owning 254.90K shares, compromising 0.10% of its total assets.
Relmada Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 27 | -72.45% |
| 31 Mar, 24 | 98 | 11.36% |
| 31 Dec, 23 | 88 | -2.22% |
| 30 Sep, 23 | 90 | -6.25% |
| 30 Jun, 23 | 96 | 3.23% |
| 31 Mar, 23 | 93 | -23.77% |
| 31 Dec, 22 | 122 | -27.38% |
| 30 Sep, 22 | 168 | 26.32% |
| 30 Jun, 22 | 133 | 1.53% |
| 31 Mar, 22 | 131 | 32.32% |
| 31 Dec, 21 | 99 | 11.24% |
| 30 Sep, 21 | 89 | -8.25% |
| 30 Jun, 21 | 97 | 7.78% |
| 31 Mar, 21 | 90 | 5.88% |
| 31 Dec, 20 | 85 | 8.97% |
| 30 Sep, 20 | 78 | -3.70% |
| 30 Jun, 20 | 81 | 84.09% |
| 31 Mar, 20 | 44 | -8.33% |
| 31 Dec, 19 | 48 | - |
As of 30 Jun 24, 27 institutions are holding Relmada Therapeutics's shares, representing a decrease of -72.45% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 3,170,425 | -77.84% |
| 31 Mar, 24 | 14,308,498 | 5.06% |
| 31 Dec, 23 | 13,619,817 | -9.16% |
| 30 Sep, 23 | 14,992,668 | -6.88% |
| 30 Jun, 23 | 16,100,099 | -9.48% |
| 31 Mar, 23 | 17,785,410 | -7.35% |
| 31 Dec, 22 | 19,197,042 | -25.55% |
| 30 Sep, 22 | 25,783,599 | 4.47% |
| 30 Jun, 22 | 24,680,979 | 6.94% |
| 31 Mar, 22 | 23,079,552 | 11.28% |
| 31 Dec, 21 | 20,740,075 | 106.83% |
| 30 Sep, 21 | 10,027,439 | 0.84% |
| 30 Jun, 21 | 9,943,993 | 4.28% |
| 31 Mar, 21 | 9,536,262 | 2.42% |
| 31 Dec, 20 | 9,311,031 | -10.85% |
| 30 Sep, 20 | 10,443,999 | -0.59% |
| 30 Jun, 20 | 10,506,204 | 12.28% |
| 31 Mar, 20 | 9,357,058 | 37.65% |
| 31 Dec, 19 | 6,797,491 | - |
Relmada Therapeutics (RLMD) has 3.17M shares outstanding as of 30 Jun 24, down -77.84% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 10.52% | 0.47% |
| 31 Mar, 24 | 47.54% | 2.32% |
| 31 Dec, 23 | 45.25% | 1.82% |
| 30 Sep, 23 | 49.81% | 1.74% |
| 30 Jun, 23 | 53.49% | 1.53% |
| 31 Mar, 23 | 59.09% | 1.41% |
| 31 Dec, 22 | 64.79% | 0.88% |
| 30 Sep, 22 | 85.76% | 1.26% |
| 30 Jun, 22 | 82.45% | 1.25% |
| 31 Mar, 22 | 81.29% | 0.58% |
| 31 Dec, 21 | 118.16% | 3.59% |
| 30 Sep, 21 | 57.37% | 1.69% |
| 30 Jun, 21 | 58.31% | 1.76% |
| 31 Mar, 21 | 57.54% | 1.61% |
| 31 Dec, 20 | 59.71% | 1.41% |
| 30 Sep, 20 | 65.09% | 1.38% |
| 30 Jun, 20 | 68.56% | 1.70% |
| 31 Mar, 20 | 63.49% | 2.98% |
| 31 Dec, 19 | 46.12% | - |
As of 30 Jun 24, Relmada Therapeutics is held by 10.52% institutional shareholders, representing a 0.47% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 9 | -78.05% |
| 31 Mar, 24 | 41 | 2.50% |
| 31 Dec, 23 | 40 | 90.48% |
| 30 Sep, 23 | 21 | -51.16% |
| 30 Jun, 23 | 43 | 26.47% |
| 31 Mar, 23 | 34 | -46.03% |
| 31 Dec, 22 | 63 | -30.00% |
| 30 Sep, 22 | 90 | 23.29% |
| 30 Jun, 22 | 73 | -2.67% |
| 31 Mar, 22 | 75 | 50.00% |
| 31 Dec, 21 | 50 | 2.04% |
| 30 Sep, 21 | 49 | 22.50% |
| 30 Jun, 21 | 40 | 29.03% |
| 31 Mar, 21 | 31 | -18.42% |
| 31 Dec, 20 | 38 | 11.76% |
| 30 Sep, 20 | 34 | -44.26% |
| 30 Jun, 20 | 61 | 117.86% |
| 31 Mar, 20 | 28 | -39.13% |
| 31 Dec, 19 | 46 | - |
9 institutional shareholders have increased their position in RLMD stock as of 30 Jun 24 compared to 41 in the previous quarter (a -78.05% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 6 | -76.00% |
| 31 Mar, 24 | 25 | 25.00% |
| 31 Dec, 23 | 20 | -50.00% |
| 30 Sep, 23 | 40 | 25.00% |
| 30 Jun, 23 | 32 | -5.88% |
| 31 Mar, 23 | 34 | -12.82% |
| 31 Dec, 22 | 39 | 14.71% |
| 30 Sep, 22 | 34 | 25.93% |
| 30 Jun, 22 | 27 | 22.73% |
| 31 Mar, 22 | 22 | -12.00% |
| 31 Dec, 21 | 25 | 92.31% |
| 30 Sep, 21 | 13 | -40.91% |
| 30 Jun, 21 | 22 | -18.52% |
| 31 Mar, 21 | 27 | 3.85% |
| 31 Dec, 20 | 26 | 23.81% |
| 30 Sep, 20 | 21 | 162.50% |
| 30 Jun, 20 | 8 | - |
| 31 Mar, 20 | 8 | - |
| 31 Dec, 19 | - | - |
6 institutional shareholders have reduced their position in RLMD stock as of 30 Jun 24 compared to 25 in the previous quarter (a -76.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 27 | -72.45% | 3,170,425 | -77.84% | 10.52% | 0.47% | 9 | -78.05% | 6 | -76.00% |
| 31 Mar, 24 | 98 | 11.36% | 14,308,498 | 5.06% | 47.54% | 2.32% | 41 | 2.50% | 25 | 25.00% |
| 31 Dec, 23 | 88 | -2.22% | 13,619,817 | -9.16% | 45.25% | 1.82% | 40 | 90.48% | 20 | -50.00% |
| 30 Sep, 23 | 90 | -6.25% | 14,992,668 | -6.88% | 49.81% | 1.74% | 21 | -51.16% | 40 | 25.00% |
| 30 Jun, 23 | 96 | 3.23% | 16,100,099 | -9.48% | 53.49% | 1.53% | 43 | 26.47% | 32 | -5.88% |
| 31 Mar, 23 | 93 | -23.77% | 17,785,410 | -7.35% | 59.09% | 1.41% | 34 | -46.03% | 34 | -12.82% |
| 31 Dec, 22 | 122 | -27.38% | 19,197,042 | -25.55% | 64.79% | 0.88% | 63 | -30.00% | 39 | 14.71% |
| 30 Sep, 22 | 168 | 26.32% | 25,783,599 | 4.47% | 85.76% | 1.26% | 90 | 23.29% | 34 | 25.93% |
| 30 Jun, 22 | 133 | 1.53% | 24,680,979 | 6.94% | 82.45% | 1.25% | 73 | -2.67% | 27 | 22.73% |
| 31 Mar, 22 | 131 | 32.32% | 23,079,552 | 11.28% | 81.29% | 0.58% | 75 | 50.00% | 22 | -12.00% |
| 31 Dec, 21 | 99 | 11.24% | 20,740,075 | 106.83% | 118.16% | 3.59% | 50 | 2.04% | 25 | 92.31% |
| 30 Sep, 21 | 89 | -8.25% | 10,027,439 | 0.84% | 57.37% | 1.69% | 49 | 22.50% | 13 | -40.91% |
| 30 Jun, 21 | 97 | 7.78% | 9,943,993 | 4.28% | 58.31% | 1.76% | 40 | 29.03% | 22 | -18.52% |
| 31 Mar, 21 | 90 | 5.88% | 9,536,262 | 2.42% | 57.54% | 1.61% | 31 | -18.42% | 27 | 3.85% |
| 31 Dec, 20 | 85 | 8.97% | 9,311,031 | -10.85% | 59.71% | 1.41% | 38 | 11.76% | 26 | 23.81% |
| 30 Sep, 20 | 78 | -3.70% | 10,443,999 | -0.59% | 65.09% | 1.38% | 34 | -44.26% | 21 | 162.50% |
| 30 Jun, 20 | 81 | 84.09% | 10,506,204 | 12.28% | 68.56% | 1.70% | 61 | 117.86% | 8 | - |
| 31 Mar, 20 | 44 | -8.33% | 9,357,058 | 37.65% | 63.49% | 2.98% | 28 | -39.13% | 8 | - |
| 31 Dec, 19 | 48 | - | 6,797,491 | - | 46.12% | - | 46 | - | - | - |
Relmada Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Relmada Therapeutics's stock was made by TRAVERSA SERGIO on May 29 2024, selling 122,358 shares at $2.48 per share (valued at $303.45K). The last insider buy of RLMD was made by TRAVERSA SERGIO on Jan 31 2024, buying 27,460 shares at $4.00 per share (worth $109.75K).
Relmada Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 9 | - | - |
| Q4 2023 | 7 | - | - |
| Q2 2023 | 9 | - | - |
| Q1 2023 | - | 2 | - |
| Q4 2022 | 8 | 3 | 266.67% |
| Q3 2022 | - | 1 | - |
| Q2 2022 | 9 | 5 | 180.00% |
| Q1 2022 | - | 2 | - |
| Q4 2021 | 7 | - | - |
| Q3 2021 | 2 | 21 | 9.52% |
| Q2 2021 | - | 5 | - |
| Q1 2021 | 31 | 81 | 38.27% |
| Q4 2020 | - | 4 | - |
| Q3 2020 | 3 | 9 | 33.33% |
| Q2 2020 | 2 | 2 | 100.00% |
| Q1 2020 | 1 | 2 | 50.00% |
| Q4 2019 | 16 | 9 | 177.78% |
| Q3 2019 | 5 | 1 | 500.00% |
| Q2 2019 | 2 | 1 | 200.00% |
| Q4 2018 | 9 | 1 | 900.00% |
9 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Relmada Therapeutics's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 9 | - | - |
| Q4 2023 | - | - | - |
| Q2 2023 | 1 | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 1 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | 3 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 5 | - |
| Q2 2021 | - | 5 | - |
| Q1 2021 | - | 58 | - |
| Q4 2020 | - | 3 | - |
| Q3 2020 | - | 3 | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 8 | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | 2 | - | - |
| Q4 2018 | 3 | - | - |
As of Q1 2024, Insider owners conducted 9 open market buy trades and 0 open market sell trades of Relmada Therapeutics's stocks.
Relmada Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| ENOB | Renovaro Biosciences Inc. |
| CYT | Cyteir Therapeutics, Inc. |
| NUVB | Nuvation Bio Inc. |
| MGTA | Dianthus Therapeutics, Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| FUSN | Fusion Pharmaceuticals Inc. |
| DYN | Dyne Therapeutics, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| EWTX | Edgewise Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| CSBR | Champions Oncology, Inc. |
| GRPH | LENZ Therapeutics, Inc. |
| NAMS | NewAmsterdam Pharma Company N.V. |
| THRD | Third Harmonic Bio, Inc. |
| NLTX | Neurogene Inc. |
| CYTK | Cytokinetics, Incorporated |
| KRTX | Karuna Therapeutics, Inc. |
| BCYC | Bicycle Therapeutics plc |
| PRDS | Pardes Biosciences, Inc. |
| STTK | Shattuck Labs, Inc. |
| RAPT | RAPT Therapeutics, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
RLMD Ownership FAQ
Who Owns Relmada Therapeutics?
Relmada Therapeutics is owned by institutional shareholders (10.52%), insiders (8.04%), and public (81.44%). The largest institutional shareholder of Relmada Therapeutics is VANGUARD GROUP INC (4.17% of total shares) and the top mutual fund owner is BlackRock Health Sciences Trust II (0.10% of total shares).
Who are the major institutional shareholders of Relmada Therapeutics?
Relmada Therapeutics's major institutional shareholders are VANGUARD GROUP INC, DEEP TRACK CAPITAL, LP, VESTAL POINT CAPITAL, LP, ACADIAN ASSET MANAGEMENT LLC, and FRANKLIN RESOURCES INC. The top five shareholders own together 19.57% of the company's share outstanding.
How many Relmada Therapeutics shareholders are there?
As of Jun 2024, there are 27 institutional shareholders of Relmada Therapeutics.
What percentage of Relmada Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 1.26M shares of Relmada Therapeutics, representing 4.17% of the company's total shares outstanding, valued at $3.77M (as of Jun 2024).
What percentage of Relmada Therapeutics is owned by DEEP TRACK CAPITAL, LP?
As of Jun 2024, DEEP TRACK CAPITAL, LP holds 1.23M shares of Relmada Therapeutics (RLMD), compromising 4.10% of the company, valued at $3.7M.
What percentage of Relmada Therapeutics is owned by VESTAL POINT CAPITAL, LP?
VESTAL POINT CAPITAL, LP is the third largest holder of Relmada Therapeutics. The company owns 1.2M of the company's shares outstanding (worth $3.6M).